(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OHTUVAYRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OHTUVAYRE

ST13

US500000098494784

Class

5, 42, 44

Filing

98494784

Registration

7750645

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

06/30/2026

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

04/11/2024

Registration date

04/08/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/08/2025

Last transaction

06/30/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

3

Owner type

99

Owner location

LONDON, GB

Examiner

DONEGAN, DANIEL P

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the literal element "OHTUVAYRE" in black stylized type with a violet semi-wave design going left to right above over the letter "V" and reaching the letter "Y", and an aquamarine wave above over the letter "V" and extending to the letter "E".

Holders and representatives

Holders

VERONA PHARMA LIMITED
Verona Pharma PLC

Representatives

Palak Mayani Merck & Co., Inc.

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma.

Class 42

Scientific research for medical purposesthe research and development of pharmaceutical preparations for the treatment of respiratory conditions and diseasein particularchronic obstructive pulmonary diseasecystic fibrosis and asthma.

Class 44

Medical treatment services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma.

Publications

History of USPTO decisions and trademark events.

34 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/29/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/29/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/29/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/29/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/29/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/29/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/20/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/08/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/02/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/05/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/05/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/05/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/05/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/18/2025

PUBO

PUBLISHED FOR OPPOSITION

02/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/12/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/21/2024

ALIE

ASSIGNED TO LIE

11/21/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/23/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/21/2024

GNSL

LETTER OF SUSPENSION E-MAILED

08/21/2024

CNSL

SUSPENSION LETTER WRITTEN

08/21/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

08/21/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/21/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

08/21/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/21/2024

DOCK

ASSIGNED TO EXAMINER

08/20/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/31/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/31/2024

NWAP

NEW APPLICATION ENTERED

04/11/2024

Continuous trademark protection

Get notified about every new filing that threatens OHTUVAYRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.